Skip to content
← Back to this collection

PUBLICATIONS · 19364962

Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2009 Jun 20
First author
Krug LM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Krug LM
      type
      Author
    2. name
      Pass HI
      type
      Author
    3. name
      Rusch VW
      type
      Author
    4. name
      Kindler HL
      type
      Author
    5. name
      Sugarbaker DJ
      type
      Author
    6. name
      Rosenzweig KE
      type
      Author
    7. name
      Flores R
      type
      Author
    8. name
      Friedberg JS
      type
      Author
    9. name
      Pisters K
      type
      Author
    10. name
      Monberg M
      type
      Author
    11. name
      Obasaju CK
      type
      Author
    12. name
      Vogelzang NJ
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Krug LM
      type
      Author
    2. name
      Pass HI
      type
      Author
    3. name
      Rusch VW
      type
      Author
    4. name
      Kindler HL
      type
      Author
    5. name
      Sugarbaker DJ
      type
      Author
    6. name
      Rosenzweig KE
      type
      Author
    7. name
      Flores R
      type
      Author
    8. name
      Friedberg JS
      type
      Author
    9. name
      Pisters K
      type
      Author
    10. name
      Monberg M
      type
      Author
    11. name
      Obasaju CK
      type
      Author
    12. name
      Vogelzang NJ
      type
      Author
    bibliography ids
    1. nci-bib-5f757166f9d0aba6aa61d9f1
    book metadata
    content sha256
    2e33e2d26e6ee168c3045dc1fe9c27745257d6509fd179df88aff13fc0739c36
    document type
    citation
    dois
    1. 10.1200/JCO.2008.20.3943
    electronic publication date
    display
    2009 Apr 13
    precision
    day
    year
    2009
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:19364962
    immutable id
    pubmed:19364962@2e33e2d26e6ee168c3045dc1fe9c27745257d6509fd179df88aff13fc0739c36
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    18
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    3007-13
    volume
    27
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      19364962
      provenance
      batch id
      4f803f1a8e7b4f56d2f1
      provider
      NCBI PubMed ESummary
      record sha256
      c4a1d349728bb984667c97278db562bf3808c2c367492e7d49b885b10bf701c0
      response sha256
      fddd7745d591ed24e15d20ce21f0a6c14874b8cee29153ff89c9892037c40127
      retrieved at
      2026-09-09T23:46:26.391289+00:00
      publication date
      display
      2009 Jun 20
      precision
      day
      year
      2009
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Multicenter Study
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/19364962/
      title
      Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.

      Preserved source evidence · Not medical advice